- Filed
- Feb 13, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Jan 31, 2020 | 13.28M sh |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $21.82M |
| Cash And Equivalents | Q1 2020 · Sep 30, 2019 | $30.44M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $49.01M |
| Stockholders Equity | Q1 2020 · Sep 30, 2019 | $49.84M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $45.63M |
| Total Liabilities | Q1 2020 · Sep 30, 2019 | $29.61M |
| Total Assets | Q1 2020 · Sep 30, 2019 | $81.21M |
| Total Assets | Q1 2020 · Dec 31, 2018 | $71.27M |
| Shares Diluted | Q1 2020 · Dec 31, 2018 | 12.72M sh |
| Stock Repurchased | Q1 2020 · Dec 31, 2018 | $101K |
| Capex | Q1 2020 · Dec 31, 2018 | $109K |
| Operating Cash Flow | Q1 2020 · Dec 31, 2018 | $3.13M |
| Eps Diluted | Q1 2020 · Dec 31, 2018 | $0.08 |
| Eps Basic | Q1 2020 · Dec 31, 2018 | $0.08 |
| Net Income | Q1 2020 · Dec 31, 2018 | $956K |
| Operating Income | Q1 2020 · Dec 31, 2018 | $1.32M |
| Revenue restated | Q1 2020 · Dec 31, 2018 | $56.86M |